Johnson & Johnson is permanently closing a South San Francisco facility that houses several divisions and is relocating 73 jobs out of California, the San Francisco Business Times reported March 30.
“The New Jersey consumer and pharmaceutical giant said it will offer relocation to all affected employees to Titusville, New Jersey, and those who do not opt to relocate will be laid off,” the Business Times stated. “The largest group of job relocations will occur at Actelion Pharmaceuticals US Inc., a Swiss company Johnson & Johnson bought in 2017, with 36 positions in marketing, administrative and medical and scientific affairs positions.”
“We are relocating our U.S. Pulmonary Hypertension home office from San Francisco, CA to Titusville, New Jersey to integrate our Pulmonary Hypertension business with the rest of our Janssen therapeutic areas, foster closer collaboration, drive growth and innovation, and broaden career opportunities for our team members,” the company said in a statement. “We are not eliminating any jobs as part of this transition. All employees whose roles are in scope have the option to relocate, and Janssen will provide assistance and cover relocation costs for employees who choose to move to the East Coast.”
Johnson & Johnson has approximately 6,000 employees in California.